The ANKRD40 Knockout HeLa Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal population derived from the HeLa human cervical carcinoma cell line, in which the ANKRD40 gene has been disrupted. This genetically heterogeneous pool of knockout cells offers a practical loss-of-function model for investigating ANKRD40 biology without the need for single-cell cloning, enabling studies across a diverse editing background that better reflects population-level responses.
HeLa cells are an immortalized cervical adenocarcinoma line, among the most extensively employed models in biomedical research due to their robust growth, ease of manipulation, and retention of key oncogenic pathways. As a standard system for cancer cell biology and general cellular studies, HeLa provides a well-characterized environment for examining the functional consequences of ANKRD40 deletion in a cervical cancer context.
ANKRD40 is an ankyrin repeat domain-containing protein predicted to function as a scaffold that coordinates protein-protein interactions. It is implicated in the regulation of cell proliferation and survival, likely through engagement with the MAPK/ERK and PI3K/AKT/mTOR signaling cascades. Upstream activators such as growth factors and oncogenic KRAS or BRAF stimulate effector kinases including MEK, ERK, and AKT, which subsequently modulate downstream targets like the anti-apoptotic regulator BCL-2 and matrix metalloproteinases (MMPs) associated with migration. ANKRD40 is hypothesized to interact with cytoskeletal or signaling partners via its four ankyrin repeats, potentially assembling complexes that fine-tune signal transduction and influence cell cycle progression, apoptosis resistance, and motility.
In the context of cervical carcinoma, ANKRD40 knockout allows functional dissection of pathways frequently dysregulated in solid tumors, including hepatocellular carcinoma and other malignancies. Disrupting ANKRD40-mediated scaffolding provides a means to evaluate shifts in phospho-ERK and phospho-AKT levels, apoptotic thresholds, and invasive behavior, shedding light on its contribution to tumorigenic phenotypes. The polyclonal format is especially suited for initial screening experiments where population average effects are measured, minimizing clonal selection bias and facilitating reproducible functional genomics.
Typical research applications for this product include functional characterization of ANKRD40, cancer biology studies, and drug target discovery. Methodologies commonly employed with these knockout cells encompass Western blotting and RT-qPCR for validation, cell viability assays (e.g., MTT or CellTiter-Glo) and colony formation assays to quantify proliferation, apoptosis assays using caspase-3/7 activity or Annexin V flow cytometry, and cell migration assays via transwell or scratch wound models. Co-immunoprecipitation can be used to probe ANKRD40 interaction partners, and phospho-specific flow cytometry or Western blotting enables analysis of ERK, AKT, and mTOR signaling. For additional details, please contact Ascent Research.
